Beginning Monday, October 5, Clemson will enact keycard access restrictions to facilities including classrooms, recreation centers and libraries. Access will be limited to students, faculty, staff and affiliates with a “cleared” status in the University’s COVID-19 system. These access control procedures will be implemented to restrict individuals who have not been cleared from entering campus facilities based on current testing and clearance requirements.

General access control guidelines put in place for students, faculty and staff include:

  • All doors will remain locked and facilities may be accessed only by using TigerOne card or Mobile ID. Click here to sign up for mobile credentials.
  • A negative COVID-19 test is required for all individuals accessing University facilities.
  • Participation in random sample testing is required.

Tests taken at Littlejohn Coliseum are automatically processed by the University and do not need to be uploaded into the University’s Upload Tool. If you are not certain about your current status, you can check it through the my.Clemson app by selecting the COVID-19 option and COVID-19 Clearance Status Tool.

If your clearance status is “Not Cleared,” and:

  • You tested negative at Littlejohn Coliseum, please contact covidsystemssupport@clemson.edu.
  • You tested at another location, please check to make sure that you have uploaded verifiable proof that you have met the requirements and your upload has been accepted within the University’s COVID-19 Test Result Upload Tool. Please note: Uploads may take up to 48 hours to be processed.

Ensuring all requirements are met and access is retained is the responsibility of each individual. Please review this information carefully and address any issues prior to October 5 to avoid any difficulties that may arise if access is denied.

Proper access control is part of the University’s commitment to the health and safety of all students, faculty, staff and affiliates. We ask everyone to please do their part to keep Clemson on a positive path forward in the face of the COVID-19 pandemic.